A carregar...
Anti-tumour activity of everolimus and sunitinib in neuroendocrine neoplasms
Comparisons between everolimus and sunitinib regarding their efficacy and safety in neuroendocrine neoplasms (NENs) are scarce. We retrospectively analysed the clinicopathological characteristics and outcomes in 92 patients with well-differentiated (WD) NEN of different origin (57 pancreatic NENs (P...
Na minha lista:
| Publicado no: | Endocr Connect |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Bioscientifica Ltd
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6528409/ https://ncbi.nlm.nih.gov/pubmed/31026812 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-19-0134 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|